迪迦
Lv3
378 积分
2024-06-26 加入
-
Chronic lymphocytic leukaemia
10天前
已完结
-
Significance of Measurable Residual Disease in Adult Philadelphia Chromosome–Positive ALL: A GRAAPH-2014 Study
1个月前
已完结
-
Significance of Measurable Residual Disease in Adult Philadelphia Chromosome–Positive ALL: A GRAAPH-2014 Study
1个月前
已关闭
-
ctDNA improves prognostic prediction in relapsed/refractory MM receiving ixazomib, lenalidomide, and dexamethasone
1个月前
已完结
-
ctDNA improves prognostic prediction in relapsed/refractory MM receiving ixazomib, lenalidomide, and dexamethasone
1个月前
已关闭
-
Genomic Determinants of Outcome in Acute Lymphoblastic Leukemia
1个月前
已完结
-
ctDNA improves prognostic prediction in relapsed/refractory MM receiving ixazomib, lenalidomide, and dexamethasone
1个月前
已完结
-
ctDNA improves prognostic prediction for patients with relapsed/refractory MM receiving ixazomib, lenalidomide, and dexamethasone
1个月前
已关闭
-
How I Use Next Generation Sequencing-MRD to Plan Approach and Prevent Relapse after HCT for Children and Adults with ALL
2个月前
已完结
-
Efficacy of melphalan, arsenic trioxide, and ascorbic acid combination therapy (MAC) in relapsed and refractory multiple myeloma
2个月前
已关闭